Cyclerion Therapeutics, Inc. (CYCN)
3.12
+0.23
(+7.96%)
USD |
NASDAQ |
Apr 14, 14:59
Cyclerion Therapeutics EPS Diluted (Quarterly) : -0.2091 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Enanta Pharmaceuticals, Inc. | -0.4153 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.799M |
| Revenue (Quarterly) | 1.025M |
| Total Expenses (Quarterly) | 1.824M |
| Enterprise Value | 9.275M |
| Profit Margin (Quarterly) | -77.95% |
| Earnings Yield | -37.70% |
| Normalized Earnings Yield | -47.32 |